← FDA DRUG APPROVALS

FDA ANDA · ANDA207440

DIFLORASONE DIACETATE

Sponsor: RISING

APPLICATION
ANDA207440
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-27
LATEST ACTION
2017-02-27
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

DIFLORASONE DIACETATEPrescription
DIFLORASONE DIACETATE 0.05% · OINTMENT · TOPICAL

Approval history

2017-02-27UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →